Norway· NO-ID_9DF08D77-02B2-45B3-ADFD-29F11F4D5AEA
Phesgo
A pertuzumab und trastuzumab product containing trastuzumab + pertuzumab, registered in Norway by Roche Registration GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Pertuzumab und trastuzumab is registered in 10 of 19 countries.
Countries holding a registration under ATC L01FY01 (pertuzumab und trastuzumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Pertuzumab und trastuzumab · ATC L01FY01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Trastuzumab + Pertuzumab
- Manufacturer
- Roche Registration GmbH
- Country
- Norway (NO)
- ATC code
- L01FY01
- ATC class
- Pertuzumab und Trastuzumab
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_9DF08D77-02B2-45B3-ADFD-29F11F4D5AEA
- no_varenummer09761215NOK 93029.3
- gtin7613326035958
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pertuzumab und trastuzumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPHESGO 1200 MG/600 MG SOLUCION INYECTABLERoche Registration Gmbh
- FinlandPhesgoAbacus Medicine A/S
- CanadaPERJETA-HERCEPTINHOFFMANN-LA ROCHE LIMITED
- FrancePHESGO 1200 mg/600 mg, solution injectableROCHE REGISTRATION (ALLEMAGNE)
- United KingdomPhesgo 1200mg/600mg/15ml solution for injection vialsRoche Products Ltd
- IrelandPhesgo 1200 mg/600 mg solution for injectionRoche Registration GmbH
- IcelandPhesgoRoche Registration GmbH*
- NetherlandsPhesgo 1200/600 mg, oplossing voor injectie in injectieflaconRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Phesgo
- Liechtenstein · Phesgo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6b24cb1b-981a-4132-8b92-193a2bc77381 GET /v1/drugs/6b24cb1b-981a-4132-8b92-193a2bc77381?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Pertuzumab og trastuzumab",
"merkevare_id": "ID_9DF08D77-02B2-45B3-ADFD-29F11F4D5AEA",
"name_form_strength": "Phesgo inj, oppl 1200 mg/600 mg",
"prescription_group": "C"
}See everything about pertuzumab und trastuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.